| General model, based on two mixed Weibull distributions of bacterial resistance, for describing various shapes of inactivation curves L Coroller, I Leguérinel, E Mettler, N Savy, P Mafart Applied and Environmental Microbiology 72 (10), 6493-6502, 2006 | 230 | 2006 |
| Survival curves of heated bacterial spores: effect of environmental factors on Weibull parameters O Couvert, S Gaillard, N Savy, P Mafart, I Leguérinel International Journal of Food Microbiology 101 (1), 73-81, 2005 | 150 | 2005 |
| Sharp large deviations for the fractional Ornstein–Uhlenbeck process B Bercu, L Coutin, N Savy Theory of Probability & Its Applications 55 (4), 575-610, 2011 | 62 | 2011 |
| Estimation of the instantaneous volatility A Alvarez, F Panloup, M Pontier, N Savy Statistical inference for stochastic processes 15, 27-59, 2012 | 50 | 2012 |
| Models for patients' recruitment in clinical trials and sensitivity analysis G Mijoule, S Savy, N Savy Statistics in Medicine 31 (16), 1655-1674, 2012 | 43 | 2012 |
| Sharp large deviations for the non-stationary Ornstein–Uhlenbeck process B Bercu, L Coutin, N Savy Stochastic Processes and their Applications 122 (10), 3393-3424, 2012 | 33 | 2012 |
| How to take into account exposure to drugs over time in pharmacoepidemiology studies of pregnant women? C Hurault‐Delarue, C Chouquet, N Savy, I Lacroix, AB Beau, ... Pharmacoepidemiology and Drug Safety 25 (7), 770-777, 2016 | 25 | 2016 |
| Estimating the causal effect of an exposure on change from baseline using directed acyclic graphs and path analysis B Lepage, S Lamy, D Dedieu, N Savy, T Lang Epidemiology 26 (1), 122-129, 2015 | 25 | 2015 |
| Upper bounds on Rubinstein distances on configuration spaces and applications L Decreusefond, A Joulin, N Savy arXiv preprint arXiv:0812.3221, 2008 | 24* | 2008 |
| An omnibus test for several hazard alternatives in prevention randomized controlled clinical trials V Garès, S Andrieu, JF Dupuy, N Savy Statistics in medicine 34 (4), 541-557, 2015 | 23 | 2015 |
| Anticipative calculus with respect to filtered Poisson processes L Decreusefond, N Savy Annales de l'IHP Probabilités et statistiques 42 (3), 343-372, 2006 | 21 | 2006 |
| Quantifying the combined effects of the heating time, the temperature and the recovery medium pH on the regrowth lag time of Bacillus cereus spores after a heat treatment S Gaillard, I Leguérinel, N Savy, P Mafart International journal of food microbiology 105 (1), 53-58, 2005 | 21 | 2005 |
| Sharp large deviations for the fractional Ornstein-Uhlenbeck process B Bercu, L Coutin, N Savy Teoriya Veroyatnostei i ee Primeneniya 55 (4), 732-771, 2010 | 19 | 2010 |
| The GMO90+ project: absence of evidence for biologically meaningful effects of genetically modified maize-based diets on wistar rats after 6-months feeding comparative trial X Coumoul, R Servien, L Juricek, Y Kaddouch-Amar, Y Lippi, L Berthelot, ... Toxicological Sciences 168 (2), 315-338, 2019 | 18 | 2019 |
| Using Poisson–gamma model to evaluate the duration of recruitment process when historical trials are available N Minois, V Lauwers‐Cances, S Savy, M Attal, S Andrieu, V Anisimov, ... Statistics in Medicine 36 (23), 3605-3620, 2017 | 17 | 2017 |
| Estimating controlled direct effects in the presence of intermediate confounding of the mediator–outcome relationship: comparison of five different methods B Lepage, D Dedieu, N Savy, T Lang Statistical methods in medical research 25 (2), 553-570, 2016 | 17 | 2016 |
| On ornstein–uhlenbeck driven by ornstein–uhlenbeck processes B Bercu, F Proïa, N Savy Statistics & Probability Letters 85, 36-44, 2014 | 17 | 2014 |
| Use of cumulative Poisson probability distribution as an estimator of the recombination rate in an expanding population: example of the Macaca fascicularis major … A Blancher, A Aarnink, N Savy, N Takahata G3: Genes| Genomes| Genetics 2 (1), 123-130, 2012 | 15 | 2012 |
| Interest of the trajectory method for the evaluation of outcomes after in utero drug exposure: example of anxiolytics and hypnotics C Hurault‐Delarue, C Chouquet, N Savy, I Lacroix, AB Beau, ... Pharmacoepidemiology and Drug Safety 26 (5), 561-569, 2017 | 14 | 2017 |
| Incremental costs in giant cell arteritis M Mounié, N Costa, L Sailler, M Lapeyre‐Mestre, R Bourrel, N Savy, ... Arthritis Care & Research 70 (7), 1074-1081, 2018 | 13 | 2018 |
